Don't Recommend a Flozin Plus GLP-1 Agonist for Most Diabetes Patients

July 2018

Buzz about CV benefits with SGLT2 inhibitors (Jardiance, etc) or GLP-1 agonists (Victoza, etc) will spark curiosity about COMBINING them.

You've probably seen the ads...that Jardiance (empagliflozin) or Victoza (liraglutide) reduce both CV risk and death in type 2 diabetes.

This sets them apart from other diabetes meds. For example, so far Invokana (canagliflozin) or Ozempic (semaglutide) only lowers CV risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote